Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT00154193
Eligibility Criteria:
Inclusion Criteria:
* Patients receiving a first heart or bilateral or single lung transplant
* Patients for whom a triple maintenance immunosuppressive therapy consisting of cyclosporine microemulsion, steroids and mycophenolate mofetil (MMF)/ enteric-coated mycophenolate sodium (EC-MPS ,(or azathioprine) is indicated.
Exclusion Criteria:
* Multi-organ transplants or previously transplanted organs
* Patients with the need of more than two cyclosporine microemulsion dosages per day
Other protocol-defined inclusion/exclusion criteria may applied
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00154193
Study Brief:
Protocol Section:
NCT00154193